Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Methoxyamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxyamine SCHEMBL3895662 | 1.00 | — | — | |
| Methoxyamine SCHEMBL2210197 | 1.00 | — | — | |
| Methoxyamine SCHEMBL11775567 | 0.94 | — | — | |
| Methoxyamine SCHEMBL29187413 | 0.94 | — | — | |
| Methoxyamine SCHEMBL567 | 0.93 | — | — | |
| Methoxyamine SCHEMBL690756 | 0.93 | — | — | |
| Methoxyamine SCHEMBL8071023 | 0.88 | — | — | |
| Methoxyamine SCHEMBL24641075 | 0.86 | — | — | |
| Methoxyamine SCHEMBL2790180 | 0.86 | — | — | |
| Methoxyamine SCHEMBL9789310 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14288 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106884-A1 | PROCESS FOR PREPARING IMMUNOGENIC AZALIDES | ZOETIS SERVICES LLC (US) | 2026-05-21 | — | — | WO | claimed |
| CN-117209426-B | Nitidine-like sulfonamide derivative and preparation method and application thereof | 广西中医药大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122036542-A | Methoxyamine hydrochloride and NO-dimethylhydroxylamine hydrochloride co-production preparation process | 湖北星昊生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122010902-A | Carbonyl substituted pyrimidine HIV-1 reverse transcriptase inhibitor and preparation method and application thereof | 山东大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4722695-A1 | PLASMONIC WELL PLATE SUBSTRATE FOR SPECTROSCOPIC ANALYSIS, AND MANUFACTURING METHOD THEREFOR | KOREA INSTITUTE OF MATERIALS SCIENCE (KR) | 2026-04-08 | — | — | EP | claimed |
| US-20250197379-A1 | NOVEL RAS INHIBITORS | SJP BIOTEC GMBH (CH) | 2025-06-19 | — | — | US | claimed |
| CN-116392858-B | Oil film remover suitable for aquaculture water and preparation method thereof | 郑州康诺生物科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120040469-A | Preparation method of rui Lu Geli and intermediate thereof | 齐鲁制药有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-120025299-A | Synthesis method of (Z) -2-methoxyimino-2-furyl ammonium acetate | 河南立诺制药有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119959423-A | Method for detecting N, N-diethyl ethylenediamine ion chromatography content in methopicloram hydrochloride bulk drug | 山东齐都药业有限公司 | 2025-05-09 | — | — | CN | claimed |
| WO-1993007902-A1 | ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS | RICHARDSON-VICKS, INC. (US) | 1993-04-29 | — | — | WO | claimed |
| US-5106581-A | Test device for detection of molybdate, vanadate and ferric ions | INDUSTRIAL TEST SYSTEMS, INC. (US) | 1992-04-21 | — | — | US | claimed |
| CN-1052854-A | The preparation method of 2-(2-furyl) thanomin | MONSANTO CO (US) | 1991-07-10 | — | — | CN | claimed |
| EP-0212588-B1 | Saturated cycloalkyl [b] pyrrole-1(2H)-acetic acid amides and derivatives thereof | WARNER-LAMBERT COMPANY (US) | 1989-12-06 | — | — | EP | claimed |
| EP-0311254-A2 | Beta-lactam compound and process for production thereof | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1989-04-12 | — | — | EP | claimed |
| EP-0212588-A1 | Saturated cycloalkyl [b] pyrrole-1(2H)-acetic acid amides and derivatives thereof | WARNER-LAMBERT COMPANY (US) | 1987-03-04 | — | — | EP | claimed |
| EP-0045631-A2 | Synthesis of dioxabicyclo(3.2.1)octanes and oxepanes | ORTHO PHARMACEUTICAL CORPORATION (US) | 1982-02-10 | — | — | EP | claimed |
| US-3981398-A | Aid in the management of clinical emergencies in medical and dental practices and other circumstances | Pienaar, Hendrik Lukas (ZA) | 1976-09-21 | — | — | US | claimed |
| US-3968245-A | Sympathomimetic topical and percutaneous administration with halogenated promoters | ALZA CORPORATION (US) | 1976-07-06 | — | — | US | claimed |
| US-3953261-A | Liquid monopropellant compositions including hydrazine and methoxylamine hydrochloride | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1976-04-27 | — | — | US | claimed |